국가: 헝가리
언어: 영어
출처: HMA (Heads of Medicines Agencies)
marbofloxacin 100 mg/ml
Miklich Laboratorios S.L
QJ01MA93
Solution for injection
marbofloxacin
Cattle, Pigs Females
2011-03-23
Revised: January 2013 AN: 01322/2012 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Quiflor 100 mg/ml Solution for Injection for Cattle and Pigs (Sows) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of solution for injection contains: ACTIVE SUBSTANCE: Marbofloxacin 100 mg EXCIPIENTS: Disodium edetate 0.10 mg Monothioglycerol 1 mg Metacresol 2 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. Clear, greenish yellow to brownish yellow solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and pigs (sows). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES CATTLE Treatment of respiratory infections caused by sensitive strains of _Pasteurella _ _multocida_, _Mannheimia haemolytica_ and _Mycoplasma bovis_. Treatment of acute mastitis caused by _Escherichia coli_ strains sensitive to marbofloxacin during the lactation period. SOWS Treatment of Metritis Mastitis Agalactia Syndrome caused by bacterial strains sensitive to marbofloxacin. The product should only be used based on susceptibility testing. 4.3 CONTRAINDICATIONS Do not administer in animals with known hypersensitivity to marbofloxacin or any other quinolone or to any of the excipients. Revised: January 2013 AN: 01322/2012 Page 2 of 5 Do not use in cases where the pathogen involved is resistant to other fluoroquinolones (cross resistance). 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use 전체 문서 읽기